- Home
- NVCR vs SGHC Comparison
NVCR vs SGHC Comparison
Compare NVCR & SGHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCR
- SGHC
- Stock Information
- Founded
- NVCR 2000
- SGHC 2020
- Country
- NVCR Switzerland
- SGHC Guernsey
- Employees
- NVCR N/A
- SGHC N/A
- Industry
- NVCR Medical/Dental Instruments
- SGHC Services-Misc. Amusement & Recreation
- Sector
- NVCR Health Care
- SGHC Consumer Discretionary
- Exchange
- NVCR Nasdaq
- SGHC Nasdaq
- Market Cap
- NVCR 1.9B
- SGHC 4.9B
- IPO Year
- NVCR 2015
- SGHC N/A
- Fundamental
- Price
- NVCR $17.60
- SGHC $11.70
- Analyst Decision
- NVCR Buy
- SGHC Strong Buy
- Analyst Count
- NVCR 7
- SGHC 6
- Target Price
- NVCR $32.43
- SGHC $12.17
- AVG Volume (30 Days)
- NVCR 1.4M
- SGHC 1.6M
- Earning Date
- NVCR 07-24-2025
- SGHC 08-06-2025
- Dividend Yield
- NVCR N/A
- SGHC 1.30%
- EPS Growth
- NVCR N/A
- SGHC 278.66
- EPS
- NVCR N/A
- SGHC 0.27
- Revenue
- NVCR $621,711,000.00
- SGHC $1,939,039,555.00
- Revenue This Year
- NVCR $5.56
- SGHC $18.57
- Revenue Next Year
- NVCR $9.19
- SGHC $9.31
- P/E Ratio
- NVCR N/A
- SGHC $43.67
- Revenue Growth
- NVCR 18.27
- SGHC 21.70
- 52 Week Low
- NVCR $14.17
- SGHC $2.94
- 52 Week High
- NVCR $34.13
- SGHC $12.18
- Technical
- Relative Strength Index (RSI)
- NVCR 49.74
- SGHC 76.04
- Support Level
- NVCR $16.81
- SGHC $10.61
- Resistance Level
- NVCR $18.59
- SGHC $12.18
- Average True Range (ATR)
- NVCR 0.74
- SGHC 0.42
- MACD
- NVCR 0.08
- SGHC 0.08
- Stochastic Oscillator
- NVCR 56.18
- SGHC 81.39
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.
About SGHC Super Group (SGHC) Limited
Super Group (SGHC) Ltd is a holding company that operates online sports betting and gaming businesses. The company's reportable segments are Betway, Spin, and Other. A majority of its revenue is generated from the Betway segment, which is a single-brand online sports betting and casino offering with licenses to operate throughout Europe, the Americas, and Africa. Spin is the company's multi-brand online casino offering, having a diverse portfolio of casino brands such as Jackpot City, Spin Casino, Dream Bingo, Mirror Bingo, etc., designed to be culturally relevant globally while aiming to offer a wide range of casino products. Geographically, the company generates maximum revenue from Africa and Middle East, followed by North America, Europe, Asia-Pacific, and South/Latin America.